Radcliffe Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Radcliffe Capital Management’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-62,500	Closed	-$638K	–	869
2020 Q4	$638K	Hold	62,500	–	–	0.04%	308
2020 Q3	$612K	Buy	+62,500	New	+$43.7K	0.06%	178

Radcliffe Capital Management's CHAQ.WS Position: Q3 2021 in Review

Radcliffe Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 62,500 shares — an estimated $623K sold.

Radcliffe Capital Management first reported a position in CHAQ.WS in Q1 2021 and held it in 2 quarters. The position peaked at $628K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

Radcliffe Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
Radcliffe Capital Management sold 62,500 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $623K.
Radcliffe Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q1 2021 and held it in 2 quarters.
Radcliffe Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $628K in Q1 2021.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Radcliffe Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.